Nachrichten zur AstraZeneca PLC Aktie

AstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030

AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.…

AstraZeneca, Amgen release mid-stage data on Tezspire for COPD

…

[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

Pfizer wins cancer drug patent case against AstraZeneca

…

AstraZeneca to manufacture ADCs in Singapore

20 May 2024 AstraZeneca plans $1.5 billion manufacturing facility for antibody drug conjugates (ADCs) in Singapore Operationally ready by 2029, it will be…

AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore

This new plant will be AstraZenecas (AZN) first manufacturing facility for producing novel antibody drug conjugates from start to finish.…

Director/PDMR Shareholding

15 May 2024 15:00 BST Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that on 13 May 2024, Pascal…

BenevolentAI and AstraZeneca discover novel heart failure target using AI

BenevolentAI (AMS:BAI, OTC:BAIVF) told investors it has reached an important milestone in its collaboration with AstraZeneca, helping the drug-maker add…

Sanofi, Pfizer, AstraZeneca invest a combined €1.87B to bolster operations in France

In two months, countries from around the world will send athletes to France to compete in the 2024 Summer Olympics.…

Microsoft, Amazon and AstraZeneca invest billions in France

Microsoft Corp (NASDAQ:MSFT) said it will join a string of mega-cap companies in investing billions into the French economy after…

Microsoft, Amazon and AstraZeneca invest billions in France

Microsoft Corp (NASDAQ:MSFT) said it will join a string of mega-cap companies in investing billions into the French economy after…

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

President Emmanuel Macron will kick off the annual Choose France event aimed at wooing big overseas businesses and investors on…

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion,…

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France By Reuters

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France…

Pfizer and AstraZeneca Announce New Investments of Nearly $1 Billion in France

PARIS (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of…

AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand

Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined.…

AstraZeneca: Vor großem Kaufsignal - Aktienanalyse

Kulmbach (www.aktiencheck.de) - AstraZeneca-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand

AstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that initially raised…

Zulassung für Impfstoff von AstraZeneca zurückgezogen

In der Europäischen Union ist der Corona-Impfstoff von AstraZeneca nicht mehr zugelassen – das habe „kommerzielle Gründe“, sagt das schwedisch-britische…

Zulassung für Astrazeneca-Impfstoff zurückgezogen - 'kommerzielle Gründe'

BRÜSSEL/HAMBURG (dpa-AFX) - Der Corona-Impfstoff des schwedisch-britischen Pharmaunternehmens Astrazeneca , Vaxzevria, ist nicht mehr in der…

Warum der Impfstoff Vaxzevria in der EU nicht mehr zugelassen ist

Seit heute ist der Corona-Impfstoff von AstraZeneca in der EU nicht mehr zugelassen. In den sozialen Medien werden Bedenken bei…

Amgen, newer rivals could threaten Novo Nordisk and Eli Lillys weight loss drug dominance

Amgen, Viking Therapeutics, Altimmune, AstraZeneca, Boehringer Ingelheim and Zealand Pharma are making encouraging progress on their own treatments.…

AstraZeneca concludes equity investment in Cellectis

AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.…

AstraZeneca completes Cellectis equity investment

7 May 2024 AstraZeneca completes equity investment agreement with Cellectis AstraZeneca today announced the successful completion of an equity investment with Cellectis,…

The Zacks Analyst Blog Highlights AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes

AstraZeneca, Qualcomm, FedEx, American International and Baker Hughes are included in this Analyst Blog.…

ANGLE announces second assay with AstraZeneca as it deepens relationship with pharma giant

…

ANGLE inks £550,000 deal with AstraZeneca for prostate cancer detection, shares jump

ANGLE plc, the AIM-listed liquid biopsy company, has inked a major supplier agreement with pharmaceutical giant AstraZeneca. The £550,000 deal…

ANGLE teams up with AstraZeneca on a second assay

ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a leader in liquid biopsy technology, has signed a supplier agreement with AstraZeneca PLC (LSE:AZN) to…

Top Analyst Reports for AstraZeneca, QUALCOMM & FedEx

Todays Research Daily features new research reports on 16 major stocks, including AstraZeneca PLC (AZN), QUALCOMM Incorporated (QCOM) and FedEx…

Calquence combination improved PFS in 1L MCL

02 May 2024 Calquence combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO…

Total Voting Rights

1 May 2024 15:00 BST Transparency Directive Voting rights and capital The following notification is made in accordance with the UK Financial Conduct…

FTC challenges junk patents held by 10 drugmakers, including for Novo Nordisks Ozempic

The agency sent letters to Novo Nordisk, AstraZeneca, Boehringer Ingelheim, Covis Pharma, GlaxoSmithKline, Novartis, Teva Pharmaceuticals, among others.…

FTSE 100 continues record run boosted by Anglo American, AstraZeneca By Reuters

FTSE 100 continues record run boosted by Anglo American, AstraZeneca…

Truqap recommended for EU breast cancer approval

29 April 2024 Truqap plusFaslodex recommended for approval in the EU by CHMP for patients with advanced ER-positive breast cancer Recommendation based on CAPItello-291 results…

Enhertu improved PFS in HER2-low and ultralow

29 April 2024 Enhertu demonstrated statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low metastatic breast cancer following one…

J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade

…

AstraZeneca: A Triple Shot Of Income, Growth, And Value

…

BHP, Anglo American, Meta, Google, Microsoft, AstraZeneca, Rubrik, ComCast and more

Markets Defused aims to present an easy-to-understand and straightforward recap of the week’s most engaging stock market news BHP takeover approach…

Pharma Stock Roundup: MRK, SNY, AZN, NVS Q1 Results, Pipeline & Regulatory Updates

Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.…

Global Pulmonary Drugs Market is Expected to Showcase a Significant Growth by 2030, Predicts DelveInsight | Key Companies - F. Hoffmann-La Roche, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Sanofi, Grifols, Regeneron

The global pulmonary drugs market is projected to experience a steady CAGR between 2024 and 2030. This growth is mainly…

dpa-AFX ProFeed